COMP <GO>
CBT vs RIO // RSI-14 & 200D SMA MOMENTUM
Cabot Corporation (NYSE) VS. Rio Tinto Plc (NYSE) • 15-METRIC TALLY: CBT 7
— RIO 3
▲ RSI-14 & 200D SMA MOMENTUM LEADER: CBT
LAST: $73.85 (+0.11%) • MKT CAP: $3.81B
rsi-technicals
43.4
LAST: $83.25 (-3.12%) • MKT CAP: $104.57B
rsi-technicals
31.2
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CBT VS. RIO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CBT | RIO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 25.30% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 22.30% | 9.90% | +12.40 | CBT | /roic <GO> |
| EV/EBITDA & P/E Valuation | 5.2x | 21.0x | -15.80 | CBT | /valuation <GO> |
| Free Cash Flow Yield | 10.25% | 2.21% | +8.04 | CBT | /fcf-yield <GO> |
| Operating Margin | 16.70% | 13.90% | +2.80 | CBT | /operating-margins <GO> |
| Net Profit Margin | 8.90% | 10.90% | -2.00 | RIO | /net-margins <GO> |
| Revenue Growth (YoY) | -7.00% | 1.10% | -8.10 | RIO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.52% | 0.00% | +2.52 | CBT | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 3.74 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 43.4 | 31.2 | +12.16 | CBT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.02 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 10.7x | 30.5x | -19.80 | CBT | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.81B | $104.57B | -$100.75B | RIO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CBT REV | RIO REV | CBT GROSS % | RIO GROSS % | CBT FCF | RIO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.71B | — | 25.3% | — | $391.0M | — |
| FY 2024 | $3.99B | — | 24.0% | — | $451.0M | — |
| FY 2023 | $3.93B | — | — | — | $595.0M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CBT // BETA —
RIO // BETA 1.02